Lessons Learned in Antibiotic Stewardship: Fluoroquinolone Use in Pediatrics

Adam L Hersh1, Jeffrey S Gerber2, Lauri A Hicks3

  • 1Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah, Salt Lake City;

Insights

Physicians rarely prescribe fluoroquinolones to children, unlike adults, due to safety concerns. This perception of harm influences antibiotic choices and impacts antibiotic stewardship efforts.

Area of Science:

  • Pharmacology
  • Pediatric Medicine
  • Infectious Diseases

Background:

  • Fluoroquinolones are frequently prescribed for adults but rarely for pediatric patients.
  • A significant disparity exists in fluoroquinolone prescribing patterns between adult and pediatric populations.
  • This difference may stem from physician perceptions regarding potential patient harm.

Purpose of the Study:

  • To investigate the reasons behind the divergent use of fluoroquinolones in adult versus pediatric care.
  • To understand the influence of perceived direct patient harm on antibiotic prescribing decisions.
  • To explore the implications of these perceptions for effective antibiotic stewardship.

Main Methods:

  • Analysis of antibiotic prescribing data in ambulatory care settings.
  • Review of physician attitudes and perceptions regarding fluoroquinolone safety in different age groups.
  • Qualitative or quantitative assessment of factors influencing antibiotic selection.

Main Results:

  • Fluoroquinolones represent the leading antibiotic class for adults in outpatient settings.
  • Conversely, fluoroquinolones are the least frequently prescribed antibiotic class for children.
  • Physician perception of direct patient harm is a key factor in this prescribing disparity.

Conclusions:

  • Physician perception of harm significantly impacts antibiotic prescribing for pediatric patients.
  • The differing use of fluoroquinolones highlights the need to address safety concerns in pediatric antibiotic decision-making.
  • Understanding these perceptions is crucial for improving antibiotic stewardship and ensuring appropriate medication use.

Related Concept Videos

Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
51
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
377
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
402
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
107
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
732
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
467